tiprankstipranks
Trending News
More News >
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Arcutis Biotherapeutics (ARQT) Income Statement

Compare
959 Followers

Arcutis Biotherapeutics Income Statement

Last quarter (Q4 2025), Arcutis Biotherapeutics's total revenue was $129.50M, an increase of 81.48% from the same quarter last year. In Q4, Arcutis Biotherapeutics's net income was $17.39M. See Arcutis Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 376.07M$ 196.54M$ 59.61M$ 3.69M$ 0.00
Gross Profit
$ 339.38M$ 177.41M$ 54.62M$ 2.93M$ -763.00K
Operating Expenses
$ 351.60M$ 305.81M$ 295.72M$ 304.56M$ 205.77M
Depreciation and Amortization
$ 5.37M$ 2.60M$ 1.88M$ 1.25M$ 763.00K
EBITDA
$ 2.48M$ -109.63M$ -227.43M$ -294.55M$ -205.59M
Operating Income
$ -12.23M$ -128.40M$ -241.10M$ -301.63M$ -206.53M
Other Income/Expenses
$ -2.74M$ -10.99M$ -17.93M$ -9.83M$ 173.00K
Pretax Income
$ -14.97M$ -139.39M$ -259.03M$ -311.46M$ -206.36M
Net Income
$ -16.14M$ -140.04M$ -262.14M$ -311.46M$ -206.36M
Per Share Metrics
Basic EPS
$ -0.13$ -1.16$ -3.78$ -5.66$ -4.17
Diluted EPS
$ -0.13$ -1.16$ -3.78$ -5.66$ -4.17
Weighted Average Shares Outstanding
127.23M 120.96M 69.31M 55.03M 49.41M
Weighted Average Shares Outstanding (Diluted)
127.23M 120.96M 69.31M 55.03M 49.41M
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History